Post-approval studies (Phase 4)Ended earlyNCT00730847
What this trial is testing
Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.
Who this might be right for
Human Papillomavirus Infection Leading to Cervical Cancer
GlaxoSmithKline 743